UKIPO rejects Novartis’s TM opposition attempt
18-06-2020
Indian drugmaker joins race to find COVID-19 vaccine
17-02-2020
J&J, HHS sign expanded deal to find COVID-19 vaccine
14-02-2020
Andrii Vodolazhskyi / Shutterstock.com
A consortium of life sciences companies including Novartis, Bristol Myers Squibb and GSK have united to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
COVID-19, coronavirus, Novartis, BMS, GSK, Gates Foundation, Wellcome Trust, vaccines, diagnostics, J&J, Pfizer, Sanofic
